Endotronix Secures $12 Million Loan from Silicon Valley Bank Amid J.P. Morgan Healthcare Conference

Woodridge, Illinois-based medical technology company Endotronix announced today that it has secured a $12 million loan from Silicon Valley Bank, coinciding with the opening of the 35th annual J.P. Morgan Healthcare Conference. Specializing in heart disease treatment, this latest funding follows Endotronix’s $32 million Series C round closed last July, which attracted investment from BioVenture Investors, SV Life Sciences (SVLS), Lumira Capital, Aperture Venture Partners, and OSF Ventures.

“The latest $12 million will be used to ‘accelerate the expansion of our clinical development programs and provide growth support for our plans to expand internationally,’” wrote Harry Rowland, CEO of Endotronix, Inc., in an email.

The aforementioned Cordella system integrates cloud-based disease management, outpatient hemodynamic management concepts, and a novel implantable pulmonary artery sensor, enabling early diagnosis before heart failure worsens or an acute episode occurs.

Cordella System’s Hardware Devices (Image from Mobihealthnews.com)

Pulmonary artery pressure testing is a method widely used in hospitals to accurately assess the severity of a patient’s heart disease. However, prior to CardioMEMS, a startup based in Atlanta (acquired by St. Jude Medical, which itself was acquired by Abbott last week), no one had successfully developed a device that could enable such monitoring at home forCardiac ConditionA Pulmonary Artery Pressure Testing System for Remote Monitoring and Timely Warning of Heart Attacks.

Although the CardioMEMS sensor has received FDA approval and has demonstrated in widespread use its ability to reduce hospital readmission rates due to congestive heart failure, it still faces a challenge: medical reimbursement. Due to the product’s high cost, many regional Medicare Administrative Contractors have refused to include it in their coverage.

Regarding the hardware reimbursement issues encountered by CardioMEMS, the CEO of Endotronix remains optimistic. He stated that Medicare will ultimately cover it once more long-term data become available.Company'sAnother idea is to use our own platform to reduce the likelihood of overwork-induced heart disease.

Digital remote patient monitoring can extract data from home medical devices, such as sensor-equipped blood pressure monitors, pulse oximeters, weight scales, and heart rate monitors, and enable data sharing among cardiologists, nurses, and collaborative caregivers. Patients and care teams can also communicate with each other.

“For clinicians, the most critical task on the backend is to derive meaningful insights from data, ensuring that appropriate emergency response protocols are in place for every potential disease condition. These measures must be established in advance to maximize the elimination of scenarios where patient treatment relies on ‘chance,’” Rowland stated in an interview last July.

Tom Hertzberg, Head of the Life Sciences & Healthcare Group at Silicon Valley Bank, stated at a press conference that it was an honor to partner with Endotronix, a company specializing in point-of-care patient management for chronic heart disease. “We have confidence in this patient-centric Cordella Heart Failure System, which helps streamline care processes, improving outcomes while reducing costs. We look forward to supporting Endotronix as it achieves greater success.”